Paper33339136
Neuroendocrine and Aggressive-Variant Prostate Cancer.
Spetsieris N and 4 others. Cancers (Basel), 2020. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Neuroendocrine and Aggressive-Variant Prostate Cancer. Papers, record 33339136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33339136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28655541 | Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. | Eur Urol | 2018 | https://conductscience.org/library/papers/28655541 | PubMed |
| 2 | 26000489 | Integrative clinical genomics of advanced prostate cancer. | Cell | 2015 | https://conductscience.org/library/papers/26000489 | PubMed |
| 3 | 30517936 | Serum Neuroendocrine Markers Predict Therapy Outcome of Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis. | Urol Int | 2019 | https://conductscience.org/library/papers/30517936 | PubMed |
| 4 | 23649003 | Platinum-based chemotherapy for variant castrate-resistant prostate cancer. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23649003 | PubMed |
| 5 | 30965328 | Large Cell Neuroendocrine Carcinoma of the Prostate: A Systematic Review and Pooled Analysis. | Urol Int | 2019 | https://conductscience.org/library/papers/30965328 | PubMed |
| 6 | 24705311 | Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. | Am J Surg Pathol | 2014 | https://conductscience.org/library/papers/24705311 | PubMed |
| 7 | 17786954 | Treatment outcomes of small cell carcinoma of the prostate: a single-center study. | Cancer | 2007 | https://conductscience.org/library/papers/17786954 | PubMed |
| 8 | 26928463 | Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. | Nat Med | 2016 | https://conductscience.org/library/papers/26928463 | PubMed |
| 9 | 25601341 | Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/25601341 | PubMed |
| 10 | 26124369 | Contemporary Incidence and Mortality Rates of Neuroendocrine Prostate Cancer. | Anticancer Res | 2015 | https://conductscience.org/library/papers/26124369 | PubMed |
| 11 | 16861969 | Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate. | Am J Surg Pathol | 2006 | https://conductscience.org/library/papers/16861969 | PubMed |
| 12 | 30337059 | Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations. | Eur Urol | 2019 | https://conductscience.org/library/papers/30337059 | PubMed |
| 13 | 28885659 | The role of serum neuron-specific enolase in patients with prostate cancer: a systematic review of the recent literature. | Int J Biol Markers | 2018 | https://conductscience.org/library/papers/28885659 | PubMed |
| 14 | 1712661 | Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. | Cancer | 1991 | https://conductscience.org/library/papers/1712661 | PubMed |
| 15 | 29949494 | Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29949494 | PubMed |
| 16 | 23850495 | Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry. | Hum Pathol | 2013 | https://conductscience.org/library/papers/23850495 | PubMed |
| 17 | 31774688 | Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study. | J Clin Oncol | 2020 | https://conductscience.org/library/papers/31774688 | PubMed |
| 18 | 29297494 | Neuroendocrine tumors of the prostate. | Mod Pathol | 2018 | https://conductscience.org/library/papers/29297494 | PubMed |
| 19 | 28059767 | Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. | Science | 2017 | https://conductscience.org/library/papers/28059767 | PubMed |
| 20 | 11958660 | Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice. | Arch Pathol Lab Med | 2002 | https://conductscience.org/library/papers/11958660 | PubMed |
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42897296 | Rare prostate cancer histologies: detection, characteristics and treatment. | Nat Rev Urol | 2026 | https://conductscience.org/library/papers/42897296 | PubMed |
| 42883702 | The Enemy of My Enemy: Two Cases of De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer with BRCA2 Alterations and Brain Metastases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883702 | PubMed |
| 42795739 | Association of Cabazitaxel Treatment Beyond 10 Cycles with Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Retrospective 8-Month Landmark Analysis. | J Clin Med | 2026 | https://conductscience.org/library/papers/42795739 | PubMed |
| 42739268 | The Prognostic Role of the Lung Immune Prognostic Index in Neuroendocrine Prostate Cancer: A Multicenter Retrospective Study. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42739268 | PubMed |
| 42569009 | Urethral Metastasis of Therapy-Induced Neuroendocrine Prostate Cancer Successfully Managed With Chemoradiotherapy: A Case Report. | IJU Case Rep | 2026 | https://conductscience.org/library/papers/42569009 | PubMed |
| 42527846 | DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives. | Drugs | 2026 | https://conductscience.org/library/papers/42527846 | PubMed |
| 42423955 | Platinum-based chemotherapy in metastatic castration-resistant prostate cancer: a narrative review and dual stratification framework based on HRR genotype and aggressive-variant/neuroendocrine phenotype. | Int Urol Nephrol | 2026 | https://conductscience.org/library/papers/42423955 | PubMed |
| 42346954 | LRRC8D Suppresses Prostate Cancer Growth and Enhances Platinum Sensitivity via Modulation of CAV-1/STAT3 Signaling. | Membranes (Basel) | 2026 | https://conductscience.org/library/papers/42346954 | PubMed |
| 42339116 | Case Report: a rare case of small cell carcinoma of the prostate. | Front Oncol | 2026 | https://conductscience.org/library/papers/42339116 | PubMed |
| 41768965 | Undifferentiated Castration-Resistant Prostate Cancer Successfully Treated With Carboplatin and Paclitaxel. | Case Rep Urol | 2026 | https://conductscience.org/library/papers/41768965 | PubMed |
| 41718350 | Transcriptomic Insights into lncRNA-miRNA-mRNA Networks Regulating Angiogenesis and Metastasis in Prostate Cancer. | BioTech (Basel) | 2026 | https://conductscience.org/library/papers/41718350 | PubMed |
| 41584790 | Clonal selection of pre-existing neuroendocrine component in prostate cancer during androgen receptor signaling inhibitor therapy: A case report. | Urol Case Rep | 2026 | https://conductscience.org/library/papers/41584790 | PubMed |
| 41547728 | Prognostic significance of neuroendocrine differentiation and PD-L1 expression in treatment-naïve prostate cancer. | BMC Urol | 2026 | https://conductscience.org/library/papers/41547728 | PubMed |
| 41097640 | EZH2 Dysregulation and Its Oncogenic Role in Human Cancers. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41097640 | PubMed |
| 40805284 | Circulating Tumor DNA in Prostate Cancer: A Dual Perspective on Early Detection and Advanced Disease Management. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805284 | PubMed |
| 40788171 | Resilience and Vulnerabilities of Tumor Cells under Purine Shortage Stress. | Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40788171 | PubMed |
| 40699451 | Reappraisal of Neuroendocrine Tumor Classification of the Prostate Gland: Translating Molecular Insights into Clinical Practice. | Endocr Pathol | 2025 | https://conductscience.org/library/papers/40699451 | PubMed |
| 40641143 | Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review). | Oncol Rep | 2025 | https://conductscience.org/library/papers/40641143 | PubMed |
| 40525978 | Update on Liquid Biopsy. | Radiology | 2025 | https://conductscience.org/library/papers/40525978 | PubMed |
| 40421291 | A prognostic model for highly aggressive prostate cancer using interpretable machine learning techniques. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40421291 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33339136
GET https://conductscience.org/api/papers/v1/33339136/references?page=2